Middle East News Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.

Press releases published on October 6, 2026

الكاتبة العُمانية نجمة البلوشي تستعد لإصدار كتاب عن الصمود والتعليم وحقوق المرأة
Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
BridgeBio to Present New Acoramidis Data, Including Independent Comparative Real-World EHR Data at the HFSA Annual Scientific Meeting 2026
BridgeBio to Present Additional Evidence from the Phase 3 CALIBRATE Trial of Encaleret in ADH1 at the ASBMR 2026 Annual Meeting
ALPHAMIN ANNOUNCES CAD$0.13 PER SHARE INTERIM FY2026 DIVIDEND/ Q3 GUIDANCE/EXPLORATION UPDATE
Big Bear Gold Corp. Announces Resumption of Trading
Gold Intersection on Globex’s Bartec Royalty Property
$10 Million and Counting: Hola Prime Hits Major Trader Payout Milestone
Outlook Therapeutics Highlights What the Appointment of New CFO Kevin Lundquist Means for the Company’s Next Chapter in Virtual Investor Discussion
Greenland Mines Authorizes $20 Million Share Repurchase Program and Announces Capital Allocation Priorities
NeOnc’s FDA Catalyst Run Could Give NTHI a Serious Jolt
Micropolis Robotics DPR2 Autonomous Patrols Lead Dubai Police’s “Proud of UAE” Cycling Race
CTERA Introduces Forward Deployed Engineering to Close the AI Skills Gap and Accelerate Enterprise Deployments
Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases
Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026
ParaZero and ThirdEye Unveil New Battlefield System Designed to Detect and Intercept Drones for Armored Vehicles
Aventis Energy Announces Fall Surface Exploration Program at the Corvo Uranium Project
SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.